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Abstract 
 
Background 
Diabetes distress is the negative emotional impact of living with diabetes. It has tangible clinical 
importance, being associated with sub-optimal self-care and glycemic control. Diabetes distress has 
been operationalized in various ways and several measures exist. Measurement clarity is needed for 
both scientific and clinical reasons.  
 
Objectives 
To clarify the conceptualization and operationalization of diabetes distress, identify and distinguish 
relevant measures, and evaluate their appropriateness for this purpose.  
 
Results 
Three measure were identified: Problem Areas in Diabetes (PAID) scale, Diabetes Distress Scale 
(DDS); Type I Diabetes Distress Scale (T1-DDS), Diabetes-specific Quality of Life Scale-Revised 
(DSQoLs-R) ‘Burden and Restrictions - Daily Hassles’ sub-scale, Well-being Questionnaire 28 (W-BQ 
28) ‘Diabetes Well-being’ sub-scale, and Illness Perceptions Questionnaire – Revised (IPQ-R) 
‘Emotional Representations’ sub-scale. Across these measures a broad spectrum of diabetes distress 
is captured, including distress associated with treatment regimen, food/eating, 
future/complications, hypoglycemia, social/interpersonal relationships, and healthcare 
professionals. No single measure appears fully comprehensive. Limited detail is reported of the 
qualitative work informing scale design, raising concerns about content validity.  
 
Conclusions 
Across the available measures diabetes distress is seemingly comprehensively assessed and 
measures should be considered in terms of their focus and scope to ensure the foci of interventions 
are appropriately targeted. 
 
 
 
Keywords: diabetes distress; patient-reported outcome measures; validity; narrative review.  
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1. Introduction 
 
Living with diabetes is complex and involves various self-care activities, e.g. medication taking, 
healthy eating, carbohydrate counting, physical activity, checking blood glucose, and problem 
solving (Peeples et al., 2007). These self-care behaviors are required to keep glycated hemoglobin 
(HbA1c) in target range, to prevent/delay onset of devastating complications (American Diabetes 
Association, 2003). The burden of self-management, living with diabetes-related complications (or 
the risk of their development), and managing difficult social situations, have the potential to cause 
considerable emotional distress. In the mid-1990s, the emotional impact of living with diabetes was 
brought to the fore, with introduction of the concept of ‘diabetes distress’ (DD) (Polonsky et al., 
1995). DD emerged from research on stress and coping, and emotional regulation in response to 
specific acute or chronic stressors, which suggests that emotions can emerge from specific 
situational contexts and that emotional distress is a response to perceptions of health threats 
balanced against an appraisal of available coping resources (Fisher, Gonzalez, & Polonsky, 2014). 
 
In recent years, research into DD has gained significant traction. Around one quarter of UK adults 
with diabetes experience elevated, or severe, DD at any given time (Dennick et al., 2016; Sturt, 
Dennick, Due-Christensen, & McCarthy, 2015). Similar rates are reported elsewhere in Europe (Stoop 
et al., 2014), Australia (Speight et al., 2011) and the USA (Fisher, Skaff, et al., 2008). Almost 50% of 
people experience elevated DD over an 18-month period (Fisher, Skaff, et al., 2008). It should be 
noted, though not the focus of this review, that DD is additionally well-documented among partners 
of those with diabetes (Polonsky, Fisher, Hessler, & Johnson, 2016), children and adolescents with 
diabetes (Hagger, Hendrieckx, Sturt, Skinner, & Speight, 2016) and parents of children and 
adolescents with diabetes (Johnson, 2013). Indeed, measures of DD specific to the needs of these 
populations have been developed (Markowitz et al., 2012; Polonsky et al., 2016; Weissberg-Benchell 
& Antisdel-Lomaglio, 2011). 
 
DD is positively associated with HbA1c, such that fluctuations in each correspond over time (Aikens, 
2012; Fisher et al., 2010; Fisher et al., 2007; Schmitt, Reimer, Kulzer, Haak, Gahr, et al., 2015), and 
reductions in DD are accompanied by clinically significant improvements in HbA1c (Strandberg, 
Graue, Wentzel-Larsen, Peyrot, & Rokne, 2014; Zagarins, Allen, Garb, & Welch, 2012). DD also 
impacts upon certain self-management behaviors (Aikens, 2012; Fisher et al., 2007).  These 
relationships have primarily been associative, however, and hence do not indicate causality. 
Individuals with high DD are less likely to participate in educational and self-management 
interventions (Fonda, McMahon, Gomes, Hickson, & Conlin, 2009), and exhibit less improvement in 
HbA1c following such interventions (Weinger & Jacobson, 2001). Conversely, when interventions 
target DD, individuals with elevated DD engage to a greater extent and this results in improved DD, 
self-management and HbA1c (Sturt, Mccarthy, et al., 2015). This emerging evidence has prompted 
calls for further interventions to target DD (Fisher et al., 2007).  
 
From a clinical perspective, measurement clarity is crucial to ensure appropriate identification of 
need and tailoring of care. From a scientific perspective, it is necessary to ensure valid 
operationalization of constructs, maximum responsiveness of measures to enable demonstration of 
effective interventions, and appropriate interpretation of data (U.S. Department of Health and 
Human Services, 2009). US and European regulatory bodies have released guidance on the 
development and use of patient-reported outcome measures (PROMs), describing the scientific rigor 
with which such measures must be developed to enable meaningful measurement and outcomes 
evaluation (European Medicines Agency Committee for Medicinal Products for Human Use, 2005; 
U.S. Department of Health and Human Services, 2009). First among the issues discussed is content 
validity, i.e. the extent to which a questionnaire measures what is claimed. A ‘conceptual model’ 
provides a representation of the relevant concepts that comprise the construct, and the 
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relationships among the concepts. It should be developed, following a systematic literature review 
and qualitative work with patients and health professionals, to inform the structure and content 
(items) of a new questionnaire.  
 
In the academic literature, the concept of DD has been assumed to be relatively simple. However, 
definition and measurement have been circular. DD is defined largely with reference to the issues 
measured by the Problem Areas in Diabetes (PAID) scale (Polonsky et al., 1995), which is widely 
regarded as the first PROM to assess DD in adults. Thus, the PAID is widely considered a suitable 
measure of DD. The more recently developed Diabetes Distress Scale (DDS) (Polonsky et al., 2005) is 
also gaining traction as a measure of DD in adults. Recent research has suggested that there are 
important content differences between the PAID and the DDS (Schmitt, Reimer, Kulzer, Haak, 
Ehrmann, et al., 2015). Until the emergence of the DDS, there had been little discussion about what 
comprises DD or of the rationale for questionnaire selection. Indeed, it is unclear whether other 
questionnaires might also be suitable for assessing DD. 
 
Furthermore, while many clinicians/researchers refer to the PAID and DDS (seemingly) appropriately 
as measures of DD, others have used broader terminology, such as (diabetes-specific) quality of life 
(Tang, Brown, Funnell, & Anderson, 2008) and diabetes-dependent impairment (Kempf & Martin, 
2013). Similarly, measures assessing other constructs (e.g. the ATT-39, which assesses diabetes 
attitudes and beliefs) have been reported as measures of DD (Esbitt, Tanenbaum, & Gonzalez, 2013; 
Snoek, Bremmer, & Hermanns, 2015). Beyond operationalizing DD with the PAID or the DDS, a 
common understanding of how to conceptualize DD and differentiate it from other commonly 
assessed constructs has not yet emerged in the literature.  
 
Previous reviews have disentangled the conceptualization and measurement of other diabetes-
specific PROMs (Garratt, Schmidt, & Fitzpatrick, 2002; Polonsky, 2000; Speight, Reaney, & Barnard, 
2009). Recently, researchers have also sought to clarify the conceptual distinction between DD and 
depression (Fisher, Gonzalez, et al., 2014; Fisher et al., 2010; Fisher et al., 2007; Snoek et al., 2015). 
To date there has been no attempt to derive a conceptual model of DD, identify and distinguish 
measures of DD from the vast array of other diabetes-specific PROMs, and explore their validity for 
this purpose.  
 
Thus, our overall aims were to: a) conceptualize and operationalize DD; b) identify measures of the 
broad concept of DD by examining their face validity in terms of measuring DD (i.e. the extent to 
which a measure looks as though it measures DD); and c) review the content validity of the 
identified measures in terms of assessing DD (i.e. the aspects of DD covered and the extent to which 
it is likely that each measure captures DD comprehensively) with a view to offering guidance on the 
context-specific selection of measures. 
 
2. Materials and methods 
 
We began by considering existing definitions of DD in order to derive a common understanding of its 
conceptualization and operationalization. Several definitions (Aikens, 2012; Esbitt et al., 2013; 
Fisher, Gonzalez, et al., 2014; Polonsky, 2000; Polonsky et al., 1995; Schmitt, Reimer, Kulzer, Haak, 
Gahr, et al., 2015; Welch, Jacobson, & Polonsky, 1997) have been applied over the past 20 years, 
ranging from a brief early description (e.g. “Breadth of emotional responses to diabetes” (p755) 
(Polonsky et al., 1995) to more recent detailed explanations (e.g. “Significant negative psychological 
reactions that are specific to one’s diabetes diagnosis, potential or actual complications, self-
management burdens, difficult patient-provider relationships, and problematic interpersonal 
relationships” (p2472) (Aikens, 2012). In summary, DD is characterized as a range of negative 
emotional responses (e.g. worry, fear, frustration, guilt, sadness, anger, overwhelm), to aspects of 
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living with and managing diabetes balanced against an appraisal of available coping resources. Living 
with and managing diabetes comprises many aspects (e.g. self-care, problem-solving, interpersonal 
relationships), each of which may be associated with a certain amount of emotional distress that can 
vary over time within and between individuals/sub-groups of people with diabetes. For example, 
sources and severity of distress can differ between those with type 1 and type 2 diabetes, and those 
managing type 2 diabetes with different treatment regimens (Baek, Tanenbaum, & Gonzalez, 2014; 
Tanenbaum, Kane, Kenowitz, & Gonzalez, 2016). These definitions offer insights into the 
conceptualization of DD and hence inform its operationalization. However, many are vague, and 
none is fully comprehensive. Collectively, they suggest that measures of DD need to focus on the 
emotional distress associated with everyday aspects of living with diabetes. 
 
The literature is replete with conceptual overlap between DD and diabetes-specific quality of life. 
We conceptualize the latter as the extent to which aspects of life (e.g. working life, family life, social 
life, finances, etc.) contributing to overall quality of life may be impaired by living with and managing 
diabetes. Diabetes can have a negative impact on quality of life without causing severe emotional 
distress, though the reverse is less likely to be true. Thus, measures of diabetes-specific quality of life 
elicit a cognitive response (considered thoughts) about the extent of the impact of diabetes on 
important aspects of life. This is contrast to DD, which is the emotional response to specific aspects 
of living with and managing diabetes. 
 
2.1 Identification and selection of measures 
We considered all diabetes-specific PROMs (suitable for completion by adults) eliciting the personal 
impact of diabetes, hence excluding measures that were evidently not focused on DD (e.g. diabetes 
knowledge and self-care). We identified the measures while conducting a published systematic 
review (Dennick et al., 2016; Sturt, Dennick, Hessler, et al., 2015) and by hand-searching published 
reviews of diabetes-specific PROMs (Eigenmann, Colagiuri, Skinner, & Trevena, 2009; El Achhab, 
Nejjari, Chikri, & Lyoussi, 2008; Hirsch, Bartholomae, & Volmer, 2000; Luscombe, 2000; Watkins & 
Connell, 2004). Any additional measures of potential relevance known to the authors were also 
included. Copies of the questionnaire and development work were obtained (e.g. from published 
papers, the internet, or direct from authors). We included measures with published psychometric 
properties and at least one citation of the development work in the previous year (Web of Science, 
December 2014), and abstracts published within the past three years (but with no citations) 
considered to be potentially ‘emerging’ measures. We considered only the full version of each 
measure, rather than short-form instruments. Where measures had been revised or English 
language papers had subsequently been published, these revised measures, and the associated 
development papers, were considered.  
 
2.2 Assessment of face validity 
Measures were assessed independently by two authors (KD/JSt) in terms of their face validity as a 
measure of DD (i.e. regardless of existing descriptions of their purpose by the scale developers or 
other authors). Decisions were verified, disagreements resolved, and consensus achieved through 
discussion with a third author (JSp). We applied the following criteria when considering the content 
of full measures and their constituent, validated sub-scales: 
 
1. Do the items relate to aspects of living with and managing diabetes (i.e. offering reasonable 
certainty that the person’s response relates to their diabetes)? For example, measures 
excluded would refer to aspects of life, activities of daily living, or social support rather than 
to diabetes, or have limited scope, focusing on an aspect of diabetes not necessarily specific 
to this, e.g. diet, exercise, anxiety or depression. 
2. Do the items elicit the emotional distress in relation to the above via their item wording? Or, 
do the completion instructions (or response options) prompt respondents to focus on 
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emotional distress? For example, measures excluded would refer to how people think about 
diabetes and its impact upon their lives rather than to how they feel about their diabetes. 
  
Where some but not all items were considered to assess DD, we determined that, for a measure to 
assess DD, at least 75% of the items would need to assess the emotional distress associated with 
diabetes. 
 
2.3 Review of content validity 
We explored content validity for assessing DD by contrasting the focus and scope of the identified 
measures in terms of the aspects of DD included and the detail associated with each respectively. 
 
3 Results 
 
3.1 Identification and selection of measures 
Figure 1 illustrates the selection process in a flow diagram. Fifty-three diabetes-specific PROMs for 
adults were identified, of which 37 had evidence of psychometric validation. Twenty-nine of these 
were measures of the personal impact of diabetes, of which 19 met our citation criteria and could be 
obtained. Citations, and the results from the citation search, for the excluded measures are available 
(online Appendix).  The 19 short-listed measures assessed comprise 91 single-factor scales or sub-
scales, of which 62 assess the personal impact of diabetes.  
 
*FIGURE 1* 
 
3.2 Face validity 
3.2.1 Measures of DD 
Table 1 illustrates the consensus decisions for each of the measures/sub-scales that were assessed.  
Three full measures and three sub-scales had sufficient face validity to be considered measures of 
DD:  
 PAID (Polonsky et al., 1995) 
 DDS (Polonsky et al., 2005)  
 Type I Diabetes Distress Scale (T1-DDS) (Fisher, Polonsky, et al., 2014; Fisher et al., 2015) 
 ‘Diabetes-specific Well-being’ sub-scale of the Well-Being Questionnaire 28 (W-BQ28) 
(Bradley, 2000; Speight & Bradley, 2002; Speight, Khagram, & Davies, 2012) 
 ‘Burdens and Restrictions - Daily Hassles’ sub-scale of the Diabetes-specific Quality of Life 
Scale (DSQoLs-R) (Bott, Muhlhauser, Overmann, & Berger, 1998; Cooke et al., 2013) 
 ‘Emotional Representations’ sub-scale of the Illness Perceptions Questionnaire – Revised 
(IPQ-R) (with ‘diabetes’ substituted for ‘illness’ as advocated by the authors) (Moss-Morris et 
al., 2002; Weinman, Petrie, Moss-Morris, & Horne, 1996) 
 
*TABLE 1* 
 
Table 2 provides a brief description of the content of the scales/sub-scales assessing DD, example 
items, the published development work, and the results from the citation search. The items in these 
measures enquire about various aspects of living with and managing diabetes; responses to two DDS 
items and one T1-DDS item cannot be specifically attributed to diabetes via the item wording but 
this is ensured via the completion instructions. Emotional distress is largely elicited via the item 
wording (e.g. DDS: ‘Feeling angry, scared and/or depressed when I think about living with diabetes’; 
DSQoLs-R ‘Burdens and Restrictions - Daily Hassles’ sub-scale: ‘It bothers me that I have to spend so 
much time on my diabetes’). Where this is not the case, DD is elicited by the instructions and 
response options (e.g. PAID instructions: ‘Which of the following diabetes issues are currently a 
‘problem’ for you?’, PAID response options: ‘not a problem – serious problem’).  
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*TABLE 2* 
 
3.2.2 Measures that capture elements of DD but with limited scope 
Eight scales/sub-scales were considered to capture elements of DD but be too limited in scope 
(Table 1). For example, the Hypoglycemia Fear Survey II (HFS-II) ‘Worry’ sub-scale (Cox, Irvine, 
Gonder-Frederick, Nowacek, & Butterfield, 1987) requires respondents to indicate how much they 
have worried about each issue (item) because of low blood glucose. The content is relevant to DD 
but highly focused on a specific aspect of living with diabetes (i.e. hypoglycemia). Similarly the 
Inhaled Insulin Treatment Questionnaire (IITQ) ‘Diabetes Worries’ sub-scale (Rubin & Peyrot, 2010) 
captures only worry related to hypo- and hyperglycemia and long-term complications. Some 
Diabetes Symptom Checklist-Revised (DSC-R) sub-scales (Arbuckle et al., 2009; Grootenhuis, Snoek, 
Heine, & Bouter, 1994) capture the emotional distress associated with diabetes symptoms. The 
emotional distress associated with other aspects of living with and managing diabetes is missing 
from these measures, thus they are too limited in scope to be considered measures of DD.  
 
3.2.3 Measures that do not assess DD 
Several measures either do not capture DD at all or are insufficiently focused on the construct (i.e. 
DD is assessed in fewer than 75% of the scale or sub-scale items). Rather, these measures typically 
elicit cognitive appraisal of the personal impact of diabetes, in other words people’s thoughts about 
the extent to which diabetes impacts on important aspects of their life, yet not the emotional 
distress associated with this (e.g. Multi-dimensional Diabetes Questionnaire (MDQ) ‘General 
Perceptions of Diabetes’ sub-scale: ‘To what extent does your diabetes interfere with your daily 
activities?’ (Talbot, Nouwen, Gingras, Gosselin, & Audet, 1997); Audit of Diabetes-Dependent Quality 
of Life (ADDQoL): ‘If I did not have diabetes my family life would be.....’ (Bradley et al., 1999); 
Appraisal of Diabetes Scale (ADS): ‘How much is your quality of life affected by the food restrictions 
required to control your diabetes?’ (Boyer & Earp, 1997). Some of these measures also comprise 
items that tap closely related but distinct constructs, for example self-efficacy and coping (Figure 1). 
The Questionnaire on Stress in Patients with Diabetes (QSD-R) (Duran, Herschbach, Waadt, Strian, & 
Zettler, 1995; Herschbach et al., 1997) is constructed such that the completion instructions/response 
options, and/or the item wording (e.g. ‘at times I can’t help worrying that I will develop 
complications later in life’), elicit emotional distress. However, many items do not enquire 
specifically about diabetes (e.g. ‘I suffer from wind’) or are cognitively framed, i.e. asking what 
people think rather than how they feel. It is likely to be more appropriate to consider such measures 
as assessing the related concept of diabetes-specific quality of life than DD.  
 
3.3 Content validity 
There was considerable variability in the operationalization of DD and therefore the focus and scope 
of the identified measures. Table 3 illustrates the aspects of DD included in each measure. Items 
were tabulated into categories based on distinct aspects of living with and managing diabetes, 
initially borne out of consideration of the empirically established DDS sub-scales (Polonsky et al., 
2005). Sub-categories were then distinguished using a bottom up approach. We mapped items onto 
the broad construct of DD where we considered that it had the best fit, so any mismatch is our own 
and not necessarily that intended by the questionnaire developers.  The shading indicates that two 
or more measures capture that particular aspect of DD, with the corresponding items appearing 
adjacently. Various aspects of DD are covered across the measures, yet there is considerable 
variability between them. No measure is fully inclusive; each one evidences omissions relative to the 
others. The measures are also variable in their coverage of some of the aspects of DD that are 
included; some operationalize an issue with a single item whereas others use several.  
 
*TABLE 3* 
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3.3.1 Treatment regimen 
The PAID, DDS, and the T1-DDS, each capture the distress associated with feeling guilty and a failure, 
and unmotivated and despondent, in relation to the treatment regimen. The DDS is more 
comprehensive than the PAID and the T1-DDS is particularly thorough in this endeavor. The TI-DDS, 
and the W-BQ 28 and DSQoLs-R sub-scales, capture treatment burden-related distress and the 
DSQoLs-R sub-scale has a narrow focus specifically on this. Indeed, treatment-regimen distress is 
frequently endorsed as a serious problem by diabetes research participants, especially those using 
insulin (Delahanty et al., 2007; Fisher, Polonsky, et al., 2014; Tanenbaum et al., 2016), and research 
has shown that it may have the largest and most uniform effect upon diabetes outcomes relative to 
other aspects of DD, especially in type 1 diabetes (Polonsky et al., 2005; Strandberg et al., 2014). 
Developed specifically for people with type 1 diabetes, it is unsurprising that the T1-DDS and the 
DSQoLs-R sub-scale focus on these aspects of DD. The DSQoLs-R was also not originally conceived as 
a measure of DD, which would explain its limited scope.  
 
3.3.2 Food/eating 
Emotional distress surrounding food and eating also ranks high amongst concerns for people with 
diabetes (Delahanty et al., 2007; Kokoszka et al., 2009; Tanenbaum et al., 2016). The PAID, DDS, T1-
DDS and DSQoLs-R sub-scale offer variable coverage of this, with the PAID and T1-DDS being most 
inclusive, whilst the W-BQ28 omits this. 
 
3.3.3 Hypoglycemia 
The T1-DDS, and to a lesser extent the PAID, uniquely elicit distress associated with hypoglycemia, 
despite the fact that fear of hypoglycemia is well recognized as a distressing aspect of diabetes 
(Delahanty et al., 2007; Kokoszka et al., 2009; Tanenbaum et al., 2016) and has been demonstrated 
to have a major impact on diabetes outcomes (Wild et al., 2007). Early measures may offer limited 
coverage of this element of DD because they were not developed specifically for insulin-treated 
diabetes and the use of insulin as a treatment option for type 2 diabetes has emerged in more 
recent years.  
 
3.3.4 Future/complications  
Worry about the future and the threat of complications has also been shown consistently, across 
many studies, to be a frequently endorsed concern amongst people with diabetes (Delahanty et al., 
2007; Kokoszka et al., 2009; Tanenbaum et al., 2016). Most of the measures, except the DSQoLs-R 
and IPQ-R sub-scales, elicit distress associated with concern about complications and/or the future, 
albeit only the PAID additionally captures distress associated with existing complications. That said, 
across these measures there is typically greater attention to daily treatment burden than distress 
associated with complications. There is evidence, however, that people not using insulin to manage 
their diabetes worry more about co-morbid medical conditions than more immediate issues, such as 
daily treatment burden (Tanenbaum et al., 2016). 
 
3.3.5 Negative emotional experiences related to diabetes 
Both the PAID and DDS offer coverage of the aspects of DD resulting from negative emotional 
experiences of living with diabetes, rather than practical or behavioral aspects of diabetes, such as 
monitoring blood glucose, albeit the PAID does so more comprehensively. These PAID items 
evidence the greatest association with depressive symptoms (Kokoszka et al., 2009) and it is the co-
morbidity of DD and low mood that seems to have the greatest impact upon HbA1c (Schmitt, 
Reimer, Kulzer, Haak, Gahr, et al., 2015). The T1-DDS and the DSQoLs-R sub-scale largely or entirely 
omit this aspect of DD. It may be that treatment burden supersedes the negative emotional 
experiences of living with type I diabetes.  The W-BQ 28 sub-scale predominantly taps this element 
of DD with a focus on negative affect and acceptance, and the IPQ-R exclusively captures this. This is 
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unsurprising given these are primarily measures of emotional well-being, with the W-BQ 28 
enquiring about diabetes generally (rather than specific aspects of managing diabetes) and the IPQ-R 
sub-scale eliciting aspects of distress resulting from negative emotional experiences that are 
applicable across illnesses. 
 
3.3.6 Social/interpersonal 
Both the W-BQ 28 and DSQoLs-R sub-scales omit distress associated with interpersonal issues and 
social support, whilst the other measures offer variable coverage of this issue. A body of evidence 
indicates that positive and negative social support behaviors have significant implications for self-
management (Tang et al., 2008), for instance spousal disregard for the treatment regimen and 
tempting with so-called ‘forbidden’ foods (Henry, Rook, Stephens, & Franks, 2013). The T1-DDS also 
uniquely elicits distress associated with an additional aspect of interpersonal DD not included in the 
other scales; fear of discrimination in relation to employment. 
 
3.3.7 Health care professionals   
The DDS and T1-DDS, and to a lesser extent the PAID, elicit distress associated with health care 
professional interactions, while the sub-scales do not capture this issue at all. People with diabetes 
report that the support (or lack of support) – informational, instrumental, emotional – from health 
care professionals is pivotal to emotional well-being and expertise in self-management (Balfe et al., 
2013; Furler et al., 2008; Thorne & Paterson, 2001). The PAID items were initially developed via 
patient interviews but also in consultation with health care professionals; perhaps provider-related 
distress was less likely to be elicited. Indeed, health care professionals cannot be presumed to 
understand every aspect of DD as people with diabetes would experience it.  
 
4 Discussion 
 
We identified three full measures and three sub-scales assessing DD. A number of other measures 
capture a very narrow aspect of this construct (e.g. hypoglycemia-related distress), and many other 
measures elicit a cognitive reflection on, rather than emotional reaction to, diabetes (i.e. items elicit 
how they think rather than how they feel about diabetes).  
 
The identified measures capture many aspects of DD as a whole, yet there is marked variability 
between them in terms of their focus and scope. None is fully inclusive. It has been reported 
previously that the PAID covers a greater variety of emotional concerns, and has a stronger focus on 
distress associated with food and eating, existing complications, and hypoglycemia, while the DDS 
focuses on health care professional and treatment regimen distress (Schmitt, Reimer, Kulzer, Haak, 
Ehrmann, et al., 2015). This finding is somewhat unsurprising given distinctions in the developer’s 
goals, and some of the relative omissions may reflect imbalance in the populations from which the 
items were derived in accordance with these aims. For example, numerous aspects of DD that are 
unique to type 1 diabetes have recently been identified (Balfe et al., 2013; Fisher et al., 2015) and 
this formed the basis for developing the T1-DDS (Fisher et al., 2015). They may also reflect 
distinctions in methodological approach; the DDS items reflect four domains considered central to 
diabetes-related emotional distress created a priori based on focus groups discussions whereas the 
PAID was not apparently informed by any such structure when it was developed 10 years earlier.  
 
The detail communicated about the development work informing scale design is also variable yet 
typically limited, though, in particular for the older measures. Explicit description of development 
work is critical so that readers are able to discern whether content validity has been achieved 
(European Medicines Agency Committee for Medicinal Products for Human Use, 2005; U.S. 
Department of Health and Human Services, 2009). In the absence of further information, and recent 
qualitative research suggesting aspects of DD that are not captured in these measures (Balfe et al., 
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2013; Tanenbaum et al., 2016), it does not appear that any single existing measure of DD meets 
required standards for assuring content validity or offers a fully comprehensive measure of DD.  
  
4.1 Limitations of identified measures 
In terms of the six measures that we identified, some important caveats are noteworthy. These 
measures are variable in the extent to which they provide a direct measure of the nature or amount 
of emotional distress experienced in relation to a stressor and instead elicit an appraisal of a stressor 
(and the extent to which this bothers them). Exemplar items from the DDS are ‘Feeling 
overwhelmed with the demands of living with diabetes’ and ‘Feeling that I am not testing my blood 
sugars frequently enough’ respectively. This issue may partly explain inconsistency in studies that 
have attempted to empirically distinguish DD and depressive symptoms (Gonzalez, Fisher, & 
Polonsky, 2011). 
 
Such nuances in item wording may also introduce content overlap with measures of other 
constructs. For example, the DDS item ‘Feeling that I am not testing my blood sugars frequently 
enough’ captures feelings of guilt and self-blame etc. associated with blood glucose testing but also 
success in executing self-management behaviors. This may explain inconsistency in associations 
between DD and self-management behaviors (Aikens, 2012; Gonzalez, Delahanty, Safren, Meigs, & 
Grant, 2008). Indeed some recent studies have restricted analyses of the association between 
diabetes distress and self-management to the emotional-burden sub-scale of the DDS to avoid 
contamination (Gonzalez, Shreck, Psaros, & Safren, 2015). 
 
4.2 Strengths and limitations of the research 
We applied a rigorous and systematic approach to identifying measures of DD, some of which have 
not previously been considered for this purpose, distinguishing these from other measures that may, 
mistakenly, be considered to measure DD. We have also brought to the fore that existing measures 
of DD differ in their focus and scope and have offered recommendations about the context-specific 
utility of each measure (European Medicines Agency Committee for Medicinal Products for Human 
Use, 2005; U.S. Department of Health and Human Services, 2009). 
 
This review is not without limitations, though. This was not a systematic review, albeit the measures 
identified were derived from a systematic search for studies that measured DD during which over 
16,000 references were screened (Dennick et al., 2016; Sturt, Dennick, Hessler, et al., 2015). 
Moreover, we applied an arbitrary threshold (at least 75% items focusing on DD) for a measure to be 
considered to assess DD. In the absence of any convention, we considered this a reasonable 
threshold to indicate a focus on DD. There was a tangible distinction between measures that met 
this criterion and those that did not. We were unable to obtain the completion instructions and/or 
scoring key for some measures, hence they could not be considered in their entirety (i.e. Well-being 
Enquiry for Diabetes (WED) (Mannucci, Ricca, Bardini, & Rotella, 1996) and Diabetes 39 (D39) (Carey 
et al., 1991). It is unlikely, however, that this information would alter the conclusion that these are 
not appropriate measures of DD. Finally, we did not assess the utility of published short forms such 
as the PAID-5 (McGuire et al., 2010) and DDS-2 (Fisher, Glasgow, Mullan, Skaff, & Polonsky, 2008). As 
the field moves forward, it is likely that these measures will become more widely used as screening 
tools and these questions may require revision. 
 
4.3 Future directions 
In the absence of detailed information about the development work underpinning the identified 
measures, and qualitative work suggesting omissions, supplementary work may be required to 
revise a measure, or measures, of DD that achieve content validity for their specific objective, and 
indeed publications that report on this, are warranted. Such endeavors need to be mindful of item 
wording, such that a direct assessment of the emotional distress experienced is attained and 
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content overlap with measures of other constructs is avoided. The work that has recently been 
undertaken in devising a measure specific to the unique issues experienced by people with type 1 
diabetes should perhaps be mirrored specifically in type 2 diabetes with attention to recent 
evidence reporting on qualitative distinctions in the source of DD according to treatment regimen 
(e.g. insulin versus oral therapies) (Tanenbaum et al., 2016). The development work underpinning 
the PAID and DDS did not distinguish between different types of diabetes, and recent evidence 
suggests type-specific measures are warranted (Fenwick et al., 2016). The main purpose of measures 
of DD is likely to remain to evaluate service delivery, medications, education or other interventions. 
Hence, further work is required to ensure that scientific measurement of DD meets international 
standards for use in clinical trials. 
 
4.4 Implications of the findings 
In terms of currently available measures, we anticipate that this review will enable clinicians and 
researchers to better identify the most appropriate measure for their purpose. When selecting a 
measure of DD, it is pertinent to ask the following questions: 
 What is my population: Type 1 or Type 2 diabetes? 
 What is my purpose in measuring DD; is my intention to capture a greater breath of the 
construct or is a shorter measure assessing a single, more focused construct 
sufficient/appropriate? 
 (For observational studies and clinical audits): Which aspects of DD do I want to 
measure/quantify? 
 (For experimental studies and interventional care pathways): What aspect of DD am I 
targeting/do I anticipate will be influenced by the intervention? 
 
Once these parameters have been established, Table 3 can be used to guide selection of DD 
measures. For example, for an intervention targeting treatment-regimen distress in adults with type 
1 diabetes, the T1-DDS would likely maximize responsiveness in outcome measurement. It should 
also be noted that readers may wish to consider using (any combination of) psychometrically-
validated sub-scales of the DDS, T1-DDS and W-BQ28, when these more narrowly defined elements 
of DD better suit the intended purpose. Similarly, readers may also wish to consider the additional 
eight scales/sub-scales considered to capture specific elements of DD but excluded from this review 
due to their limited scope (see Table 1). 
 
5 Conclusions 
 
We have presented a conceptualization and operationalization of DD, isolated six appropriate 
measures of DD, distinguished them from other related measures, and offered guidance on their 
context-specific selection. Further research may be required to optimize the content validity of the 
measures identified in terms of assessing DD to meet international standards for use in clinical trials. 
Across the available measures, though, DD is seemingly comprehensively assessed and measures 
should be considered in terms of their focus and scope to ensure that the foci of interventions are 
appropriately targeted. 
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Appendix: Citations associated with the excluded measures  
Citations associated with each of the excluded measures and results from the citation search 
for these measures. 
Measure Citations 
 
Total No. 
citations 
Most 
recent 
citation 
aMeasures not appropriately validated 
Diabetes-Related 
Knowledge and 
Psychosocial 
Functioning 
Questionnaire  
Gilden, J. L., Hendryx, M., Casia, C., & Singh, S. P. (1989). The 
effectiveness of diabetes education programs for older patients and their 
spouses. J Am Geriatr Soc, 37(11), 1023-1030. 
Gilden, J. L., Hendryx, M. S., Clar, S., Casia, C., & Singh, S. P. (1992). 
Diabetes support groups improve health care of older diabetic patients. J 
Am Geriatr Soc, 40(2), 147-150. 
NA 
Quality of Life with 
Diabetes (LDQ) scale  
Fenwick, E. K., Rees, G., Holmes-Truscott, E., Browne, J. L., Pouwer, F., 
& Speight, J. (2016). What is the best measure for assessing diabetes 
distress? A comparison of the Problem Areas in Diabetes and Diabetes 
Distress Scale: results from Diabetes MILES-Australia. J Health Psychol, 
pii: 1359105316642006. 
Hirsch, A., Bartholomae, C., & Volmer, T. (1997). General and disease 
specific quality of life measures in people with diabetes. Paper presented at 
the 13th Annual Meeting of the International Society of Technology 
Assessment in Health Care, Barcelona.  
Hirsch, A., Bartholomae, C., & Volmer, T. (2000). Dimensions of quality 
of life in people with non-insulin-dependent diabetes. Qual Life Res, 9(2), 
207-218. 
NA 
Diabetes Symptom 
Distress Questionnaire  
Anderson, R.  , & Testa, M. (1994). Symptom distress checklists as a 
component of quality of life measurement. Drug Inf J, 28(89-114). 
NA 
Perceived Threat of 
Diabetes  
Connell, C. M., Davis, W. K., Gallant, M. P., & Sharpe, P. A. (1994). 
Impact of social support, social cognitive variables, and perceived threat 
on depression among adults with diabetes. Health Psychol, 13(3), 263-273. 
NA 
Diabetes-Related Stress  Dalfrà, M.G., Nicolucci, A., Bisson, T., Bonsembiante, B., & Lapolla, A. 
(2012). Quality of life in pregnancy and post-partum: a study in diabetic 
patients. Qual Life Res, 21(2), 291-298. 
De Berardis, G., Franciosi, M., Belfiglio, M., Di Nardo, B., Greenfield, S., 
Kaplan, S.H., . . . The Quality of Care and Outcomes in Type 2 Diabetes 
(QuED) Study Group. (2002). Erectile dysfunction and quality of life in 
type 2 diabetic patients: a serious problem too often overlooked. Diabetes 
Care 25(2), 284-291. 
NA 
Diabetes Health 
Distress  
Dalfrà, M.G., Nicolucci, A., Bisson, T., Bonsembiante, B., & Lapolla, A. 
(2012). Quality of life in pregnancy and post-partum: a study in diabetic 
patients. Qual Life Res, 21(2), 291-298. 
De Berardis, G., Franciosi, M., Belfiglio, M., Di Nardo, B., Greenfield, S., 
Kaplan, S.H., . . . The Quality of Care and Outcomes in Type 2 Diabetes 
(QuED) Study Group. (2002). Erectile dysfunction and quality of life in 
type 2 diabetic patients: a serious problem too often overlooked. Diabetes 
Care 25(2), 284-291. 
NA 
Diabetes Hassles 
Questionnaire  
Cox, D. J., Taylor, A. G., Nowacek, G., Holleywilcox, P., Pohl, S. L., & 
Guthrow, E. (1984). The Relationship between Psychological Stress and 
Insulin-Dependent Diabetic Blood-Glucose Control - Preliminary 
Investigations. Health Psychol, 3(1), 63-75. 
Weinger, K., & Jacobson, A. M. (2001). Psychosocial and quality of life 
correlates of glycemic control during intensive treatment of type 1 
diabetes. Patient Educ Couns, 42(2), 123-131. 
NA 
Diabetes Impact Survey (no reference identified) NA 
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Measure Citations 
 
Total No. 
citations 
Most 
recent 
citation 
Diabetes Emotional 
Impact Questionnaire 
(no reference identified) NA 
The Diabetes 
Questionnaire (TDQ)  
(no reference identified) NA 
bMeasures not indexed in database to facilitate citation search 
The Diabetes Quality of 
Life Brief Clinical 
Inventory  
Burroughs, T.E., Desikan, R., Waterman, B.M., Gilin, D., & McGill, J. 
(2004). A brief, treatment-focused version of the Diabetes Quality of Life 
(DQOL) questionnaire for use with both type 1 and type 2 diabetes. 
Diabetes Spectr, 17(1), 41-49. 
NA 
Elderly Diabetes 
Burden Scale (EDBS) 
Araki, A., & Ito, H. . (2003). Development of elderly diabetes burden scale 
for elderly patients with diabetes mellitus. Geriatr Gerontol Int, 3, 
212-222. 
NA 
Diabetes Quality of 
Life Questionnaire 
(DQLQ)  
Henderson, M.J., & Tindall, H. (1990). Evaluation of consumer 
satisfaction and quality of life in patients changing to Novopen II. Practical 
Diabetes International, 7, 206-208. 
NA 
The Problem Areas in 
Life with Diabetes 
(PLD) questionnaire  
Kulzer, B, Bauer, U., Hermanns, H., & Bergis, K.H. (1995). Entwicklung 
eines Problemfragebogens für Diabetiker zur Identifikation von 
Schulungseinheiten im Umgang mit der Krankheit. Verhaltenstherapie, 
5(Suppl 1), 72. 
NA 
The Ideas About 
Diabetes—Revised 
(IAD-R) scale  
Dion, G.A. (1990). Testing of an instrument to measure acceptance of 
diabetes: Ideas About Diabetes—Revised (IAD-R). Louisiana State 
University, New Orleans.    
NA 
Diabetes-specific Stress 
Perceptions (DSSP) 
scale 
Su, Y.L., Zhang, M., & Chen, Y.Z. (1994). The relationship of stress 
perceptions and coping of non-insulin-dependent diabetes mellitus patients 
in a outpatient department. Nursing Research (Taiwan, China), 2, 30-40. 
NA 
cMeasures not assessing the personal impact of diabetes 
Diabetes Obstacles 
Questionnaire (DOQ)  
Hearnshaw, H., Wright, K., Dale, J., Sturt, J., Vermeire, E., & van Royen, 
P. (2007). Development and validation of the Diabetes Obstacles 
Questionnaire (DOQ) to assess obstacles in living with Type 2 diabetes. 
Diabet Med, 24(8), 878-882. 
NA 
Diabetes Care Profile 
(DCP)  
Fitzgerald, J. T., Davis, W. K., Connell, C. M., Hess, G. E., Funnell, M. 
M., & Hiss, R. G. (1996). Development and validation of the Diabetes 
Care Profile. Eval Health Prof, 19(2), 208-230. 
NA 
The Diabetes 
Integration Scale 
(ATT39)  
Dunn, S. M., Smartt, H. H., Beeney, L. J., & Turtle, J. R. (1986). 
Measurement of emotional adjustment in diabetic patients: validity and 
reliability of ATT39. Diabetes Care, 9(5), 480-489. 
Welch, G., Beeney, L., Dunn, S.M., & Smith, R.B.W. (1996). The 
development of the diabetes integration scale: a psychometric study of the 
ATT39. Multivariate Experimental Clinical Research, 11(2), 75-88. 
NA 
Diabetes Attitudes 
Scale (DAS)  
Anderson, R.M., Donnelly, M.B., Gressard, C., & Dedrick, R.F.    (1989). 
The development of a diabetes attitude scale for health care professionals. 
Diabetes Care, 12, 120-127. 
NA 
The Barriers to Insulin 
Treatment 
Questionnaire  
Petrak, F., Stridde, E., Leverkus, F., Crispin, A. A., Forst, T., & Pfutzner, 
A. (2007). Development and validation of a new measure to evaluate 
psychological resistance to insulin treatment. Diabetes Care, 30(9), 2199-
2204. 
NA 
The Personal Diabetes 
Questionnaire (PDQ)  
Stetson, B., Schlundt, D., Rothschild, C., Floyd, J. E., Rogers, W., & 
Mokshagundam, S. P. (2011). Development and validation of The Personal 
Diabetes Questionnaire (PDQ): a measure of diabetes self-care behaviors, 
perceptions and barriers. Diabetes Res Clin Pract, 91(3), 321-
332. 
NA 
The Barriers in 
Diabetes Questionniare  
Mollem, E. D., Snoek, F. J., & Heine, R. J. (1996). Assessment of 
perceived barriers in self-care of insulin-requiring diabetic patients. Patient 
Educ Couns, 29(3), 277-281. 
Willemse, G. (1989). Waargenomen barrieres bij diabetespatienten 
(Perceived barriers in diabetic patients). PhD, Catholic University Brabant, 
Tilburg.    
NA 
The Acceptance and 
Action Questionniare - 
II (AAQ-II) (diabetes 
version)  
Bond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., 
Orcutt, H. K., . . . Zettle, R. D. (2011). Preliminary psychometric 
properties of the Acceptance and Action Questionnaire-II: a revised 
measure of psychological inflexibility and experiential avoidance. Behav 
Ther, 42(4), 676-688. 
NA 
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Measure Citations 
 
Total No. 
citations 
Most 
recent 
citation 
Gregg, J. A., Callaghan, G. M., Hayes, S. C., & Glenn-Lawson, J. L. 
(2007). Improving diabetes self-management through acceptance, 
mindfulness, and values: a randomized controlled trial. J Consult Clin 
Psychol, 75(2), 336-343. 
Schmitt, A., Reimer, A., Kulzer, B., Haak, T., Gahr, A., & Hermanns, N. 
(2014). Assessment of diabetes acceptance can help identify patients with 
ineffective diabetes self-care and poor diabetes control. Diabet Med, 
31(11), 1446-1451. 
Schmitt A, Gahr A, Hermanns N, Kulzer B, Haak T. (2013). Evaluation der 
deutschen Fassung des Fragebogens AADQ zur Diabetesakzeptanz: der 
Acceptance and Action Diabetes Questionnaire in Deutscher fassung 
eignet sich fur wissenschaft und klinik. Diabetes Stoffw Herz, 22. 
dMeasures that could not be obtained 
Diabetes Quality of 
Life Clinical Trial 
Questionnaire 
(DQLCTQ-R)  
Shen, W., Kotsanos, J. G., Huster, W. J., Mathias, S. D., Andrejasich, C. 
M., & Patrick, D. L. (1999). Development and validation of the Diabetes 
Quality of Life Clinical Trial Questionnaire. Med Care, 37(4 Suppl Lilly), 
AS45-66. 
NA 
eMeasures assessing the personal impact of diabetes but not meeting citation criteria 
Diabetes Fear of 
Injecting and Self-
testing Questionnaire 
(D-FISQ)  
Snoek, F. J., Mollema, E. D., Heine, R. J., Bouter, L. M., & van der Ploeg, 
H. M. (1997). Development and validation of the diabetes fear of injecting 
and self-testing questionnaire (D-FISQ): first findings. Diabet Med, 
14(10), 871-876. 
19 AUG 
2013 
Diabetes Diet-related 
QoL Scale  
Sato, E., Suzukamo, Y., Miyashita, ., & Kazuma, K. (2004). 
Development of a diabetes diet-related quality-of-life scale. Diabetes Care, 
27(6), 1271-1275. 
5  JAN 
2013 
Diabetes Impact 
Measurement Scales 
(DIMS)  
Hammond, G. S., & Aoki, T. T. (1992). Measurement of health status in 
diabetic patients. Diabetes impact measurement scales. Diabetes Care, 
15(4), 469-477. 
40 
 
OCT 
2013 
Newcastle Diabetes 
Symptoms 
Questionnaire (NDSQ)  
McColl, E., Steen, I. N., Meadows, K. A., Hutchinson, A., Eccles, M. P., 
Hewison, J., . . . Blades, S. M. (1995). Developing outcome measures for 
ambulatory care--an application to asthma and diabetes. Soc Sci Med, 
41(10), 1339-1348. 
18  SEP 
2011 
Diabetes Health Status 
Questionnaire  
Wierenga, M. E. (1994). Life-style modification for weight control to 
improve diabetes health status. Patient Educ Couns, 23(1), 33-40. 
17 DEC 
2012 
Diabetes Emotional 
Adjustment Scale 
(DEAS)  
De Leon, O. A. (1995). Development, reliability and validation of the 
Diabetes Emotional Adjustment Scale in Spanish: preliminary findings. Int 
J Psychiatry Med, 25(1), 81-92. 
1  JAN 
2003 
Quality of Life Scale 
for Diabetes Mellitus 
(DMQLS)  
Wang, L. S., Sun, Z. Q., Cai, T. S., & Zhou, Z. G. (2005). Development 
and evaluation of quality of life scale for patients with type 2 diabetes 
mellitus. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 30(1), 21-27. 
3 
 
JAN 
2013 
The Quality of Life 
Status and Change 
Instrument  
Hornquist, J. O., Wikby, A., Hansson, B., & Andersson, P. O. (1993). 
Quality of life: status and change (QLsc) reliability, validity and sensitivity 
of a generic assessment approach tailored for diabetes. Qual Life Res, 2(4), 
263-279.  
17  APR 
2009 
Fear of Hypoglycemia 
Scale (FH-15)  
Anarte Ortiz, M. T., Caballero, F. F., Ruiz de Adana, M. S., Rondan, R. 
M., Carreira, M., Dominguez-Lopez, M., . . . Soriguer, F. C. (2011). 
Development of a new fear of hypoglycemia scale: FH-15. Psychological 
assessment, 23(2), 398-405. 
0  
 
NA 
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Table 1 Face validity of short-listed measures 
 
Face validity for assessing diabetes distress of each of the nineteen short-listed measures. 
 
Questionnaire abbreviation: name 
[ref(s)] 
Full measure 
of DD; ≥75% 
items DD? 
Sub-scale(s) measure of DD? 
PAID: Problem Areas in Diabetes 
(Polonsky et al., 1995) 
Yes No sub-scales recommended 
DDS: Diabetes Distress Scale (Polonsky 
et al., 2005) 
Yes Yes – ‘Emotional Burden’, ‘Physician-related 
Distress’, ‘Regimen-related Distress’ & 
‘Interpersonal Distress’ ≥75% items DD 
T1-DDS: Type 1 Diabetes Distress Scale  
(Fisher, Polonsky, et al., 2014; Fisher et 
al., 2015) 
 
Yes Yes - all sub-scales ≥75% items DD (i.e. 
‘Powerlessness’, ‘Management Distress’, 
‘Hypoglycemia Distress’, ‘Negative Social 
Perceptions’, ‘Eating Distress’, ‘Physician Distress’ 
& ‘Friend/family Distress’) 
W-BQ28: Well-being Questionnaire 28-
item version (Diabetes-specific Well-
being sub-scale) (Bradley, 2000; Speight 
& Bradley, 2002; Speight et al., 2012). 
 
Yes  Yes - all sub-scales ≥75% items DD (i.e. ‘Diabetes-
specific Negative Well-being’, ‘Diabetes-specific 
Positive Well-being’ & ‘Diabetes-specific Stress’) 
DSQoLs-R: Diabetes-specific Quality of 
life Scale-Revised (Burdens and 
Restrictions sub-scale) (Bott et al., 1998; 
Cooke et al., 2013) 
 
No  Yes - ‘Daily Hassles’ ≥75% items DD 
No - ‘Anxiety About the Future’ & ‘Fear of 
Hypoglycemia’ sub-scales ≥75% items DD but 
limited scope (‘Social Aspects’, Dietary Restraint’ & 
‘Physical Complaints’ sub-scales <75% items DD) 
IPQ-R: Illness Perceptions Questionnaire 
– Revised (Moss-Morris et al., 2002; 
Weinman et al., 1996) 
 
N/A Yes - ‘Emotional Representations’ ≥75% Items DD 
(‘Identity’ & ‘Consequences’ sub-scales <75% Items 
DD) 
DSC-R: Diabetes Symptom Checklist-
Revised (Arbuckle et al., 2009; 
Grootenhuis et al., 1994) 
 
No  No - Neurology–sensory, Ophthalmology & 
Hyperglycemia sub-scales ≥75% Items DD but 
limited scope (‘Psychology, cognitive’, ‘Psychology, 
fatigue’, ‘Neurology, pain’, ‘Cardiology’ & 
‘Hypoglycemia’ sub-scales <75% Items DD) 
HFS-II: Hypoglycemia Fear Survey II (Cox 
et al., 1987) 
N/A No - ‘Worry’ sub-scale ≥75% Items DD but limited 
scope (‘Part 2’ sub-scale <75% Items DD) 
DQoL: Diabetes Quality of Life measure 
(Jacobson, Barofsky, Cleary, Rand, & The 
DCCT Research Group, 1988) 
N/A No - ‘Diabetes-related Worry’ ≥75% Items DD but 
limited scope (‘Impact’ sub-scale <75% Items DD) 
IITQ: Inhaled Insulin Treatment 
Questionnaire (Rubin & Peyrot, 2010) 
N/A No – ‘Diabetes Worries’ ≥75% Items DD but limited 
scope 
QSD-R: Questionnaire on Stress in 
patients with Diabetes – Revised (Duran 
et al., 1995; Herschbach et al., 1997) 
 
No  No – all sub-scales <75% Items DD  (i.e. ‘Leisure 
Time’, ‘Depression/Fear of Future’, ‘Hypoglycemia’, 
‘Self-medication’, ‘Physical Complaints’, ‘Work’, 
‘Partner’ & ‘Doctor-patient Relationship’) 
IDSRQ: Insulin Delivery Self-rating 
Questionnaire (Peyrot & Rubin, 2005) 
N/A No – all sub-scales <75% Items DD (i.e. ‘Impact of 
Treatment on Daily Activities’, ‘Diabetes-related 
Worries’, ‘Social Burdens’ & ‘Psychological Well-
being’) 
WED: Well-being Enquiry for Diabetics 
(Mannucci et al., 1996) 
No  No – all sub-scales <75% Items DD (i.e. ‘Symptoms’, 
‘Discomfort’, ‘Serenity’, ‘impact’) 
DHP: Diabetes Health Profile (Meadows 
et al., 1996) 
No  No sub-scales 
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ADDQoL: Audit of Diabetes-Dependent 
Quality of Life  (Bradley et al., 1999) 
No  No sub-scales 
ADS: Appraisal of Diabetes Scale (Carey 
et al., 1991) 
No  No sub-scales 
MDQ: Multi-dimensional Diabetes 
Questionnaire (General Perceptions of 
Diabetes sub-scale) (Talbot et al., 1997)  
N/A No – all sub-scales <75% Items DD (i.e. 
‘Interference’ & ‘Severity’) 
D39: Diabetes 39 (Boyer & Earp, 1997) No No – all sub-scales <75% Items DD (I.e. ‘Energy & 
Mobility’, ‘Diabetes Control’, ‘Anxiety & Worry’, 
‘Social & Peer burden’ & ‘Sexual Functioning’) 
(scoring key not available; composition of sub-
scales not known but no items DD) 
FOC: Fear of Complications 
questionnaire (Taylor, Crawford, & 
Gold, 2005) 
No No sub-scales 
 
N/A: The full measure was not assessed rather one or more sub-scales were excluded because they did not 
assess the personal impact of diabetes. 
Citations in bold distinguish the version of the measure and development paper that was considered. 
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Table 2 Measures/sub-scales capturing diabetes distress 
 
Brief description of the measures/sub-scales capturing diabetes distress. 
 
Questionnaire 
abbreviation: 
name [ref(s)]; 
Total citations 
(most recent 
year) 
Relevant 
subscales (no. 
items) 
Completion instructions Example items Response 
options 
Development work Psychometric properties 
PAID:  
Problem Areas in 
Diabetes  
 
320 citations 
(2014)  
No sub-scales 
recommended 
(20) 
‘Which of the following 
diabetes issues are 
currently a problem for 
you?’ 
‘Feeling scared when 
you think about living 
with diabetes’
a
 and 
‘feelings of 
deprivation regarding 
food and meals’
b 
5 point 
scale (‘not 
a problem’ 
to ‘serious 
problem’) 
Items generated with 10 HCPs 
(including diabetes nurse specialists, 
dieticians and diabetologists) and 
during routine patient interviews 
(focusing on difficulties experienced 
in living with diabetes). Piloted on 25 
insulin requiring female patients 
(predominantly T1D), with item 
revisions (Polonsky et al., 1995). 
Internal reliability (α=.95) and 
convergent (HbA1c, general distress, 
psycho-social functioning, fear of 
hypoglycemia and disordered eating) 
and known groups (diabetes type) 
validity established in a sample of 
insulin requiring female patients 
(n=451) (Polonsky et al., 1995). 
DDS:  
Diabetes Distress 
Scale  
 
146 citations 
(2014) 
‘Emotional 
Burden’ (3), 
‘Physician-
related Distress’ 
(4), ‘Regimen-
related Distress’ 
(5), 
‘Interpersonal 
Distress’ (3) 
‘Consider the degree to 
which each of the items 
may have distressed or 
bothered you during the 
past month’ (plus 
prompted to indicate 
how much they are 
bothered by each item 
not whether it is merely 
true and preamble - life 
with diabetes can be 
tough and result in many 
problems and hassles 
that vary in severity and 
the items reflect problem 
areas that people with 
diabetes may experience) 
‘Feeling angry, scared 
and/or depressed 
when I think about 
living with diabetes’
a 
(Emotional Burden) 
and ‘feeling that I am 
often failing with my 
diabetes routine’
b 
(Regimen-related 
Distress) 
6 point 
scale (‘not 
a problem’ 
to ‘a very 
serious 
problem’) 
Items generated by people with 
diabetes & HCPs (including diabetes 
nurse specialists, dieticians, 
diabetologists and diabetes-
knowledgeable psychologists), based 
on a priori domains of diabetes 
distress and review of PAID, QSD-R 
and ATT39 items (new & similar 
items suggested). Piloted on several 
small groups of patients (not 
described), with item revisions 
(Polonsky et al., 2005). 
Internal reliability (α=.93) and 
convergent (depressive symptoms, 
self-care behaviour, cholesterol) and 
known groups (regimen type) validity 
were established at the full measure 
and sub-scale level in diverse multi-
site samples of patients with Type 1 
and T2D participating in larger trial 
and observational studies (n=683) 
(Polonsky et al., 2005). 
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T1-DDS:  
Type 1 Diabetes 
Distress Scale 
 
No citations† 
‘Powerlessness’ 
(5), 
‘Management 
Distress’ (4), 
‘Hypoglycemia 
Distress’ (4), 
‘Negative Social 
Perceptions’ (4), 
‘Eating Distress’ 
(3), ‘Physician 
Distress’ (4), 
‘Friend/family 
Distress’ (4). 
‘Indicate the degree to 
which each of the 
following may have been 
a problem for you’ (plus 
prompted that ‘a very 
serious problem’ 
indicates it has been very 
tough over the past 
month and preamble – 
‘living with T1D can be 
tough and the items 
reflect the distressing 
things that people with 
diabetes may 
experience)’ 
‘Feeling worried that I 
will develop serious 
long-term 
complications no 
matter how hard I 
try’
a
 (Powerlessness) 
and ‘Feeling that my 
eating is out of 
control’
b 
(Eating 
Distress) 
6 point 
scale (‘not 
a problem’ 
to ‘a very 
serious 
problem’) 
Items generated via literature review 
and interviews with adult patients 
with T1D stratified by age, gender, 
and years with T1D (n=25; 
interviewees ere asked ‘What about 
T1D drives you crazy?’ and ‘What 
particular aspects of diabetes are the 
most difficult for you?’) & HCPs 
(n=10). Responses were reviewed for 
duplication, converted to survey 
items and reviewed by patients/HCPs 
for clarity. Validated in 414 patients 
with T1D from the USA and Canada, 
with item reduction (Fisher et al., 
2015). 
Internal reliability (α=.91 & .92 
respectively) and construct validity 
(quality of life, depressive symptoms, 
fear of hypoglycemia (worry sub-
scale), HbA1c, and number of 
complications) were established at 
the final full measure and sub-scale 
level (in the aforementioned sample) 
(Fisher et al., 2015) 
W-BQ28:  
Well-being 
Questionnaire 
28-item version 
(‘Diabetes-
specific Well-
being’ sub-scale)   
 
No citations 
‘Diabetes-
specific 
Negative Well-
being’ (4), 
‘Diabetes-
specific Positive 
Well-being’ (4), 
‘Diabetes-
specific Stress’  
(4) 
‘Circle one number to 
indicate how often you 
feel each statement has 
applied to you in the past 
few weeks’ (and 
prompted the diabetes 
well-being sub-scale 
items are concerned with 
the effects of your 
diabetes)  
‘Because of my 
diabetes I worry 
about the future’
a 
(Diabetes-specific 
Negative Well-being) 
and ‘I feel stressed by 
keeping to a schedule 
with my diabetes’
 a 
(Diabetes-specific 
Stress) 
4 point 
scale (‘all 
the time’ 
to ‘not at 
all’) 
Extended version of the W-BQ12: 
new stress and diabetes-specific well-
being/stress items were generated, 
but method not reported 
(development work published in 
conference abstract only [28]). 
Piloted on N=789 diabetes 
outpatients in DIABQoL+ study, with 
item revisions (Speight & Bradley, 
2002). 
Preliminary psychometric validation 
suggested internal reliability (at the 
sub-scale level α=.80-.87), test-retest 
reliability (.79), convergent validity 
(HbA1c) and sensitivity to change 
[28]. Internal reliability (α=.84-.90), 
convergent (correlations between W-
BQ28 sub-scales), divergent 
(treatment satisfaction and self-care) 
and known-groups (age, gender and 
HbA1c) validity were subsequently 
confirmed at the full-scale and sub-
scale level and published in a sample 
of people with T2D (n=353) (Speight 
et al., 2012). 
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DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised 
(Burdens and 
Restrictions sub-
scale)  
 
No citations 
‘Daily Hassles’ 
(5)  
‘Which burdens and 
restrictions from 
diabetes and its 
treatment have you 
experienced during the 
last 4 weeks’ (plus 
prompted ‘we want to 
understand to what 
extent diabetes bothers 
you in your daily life’ and 
preamble - diabetes is for 
most people associated 
with several restrictions 
and burdens) 
 ‘It bothers me that I 
have to take my 
medical instruments 
with me whatever I 
do’
a
 and ‘It bothers 
me that I have to 
spend so much time 
on my diabetes 
treatment’
a   
6 point 
scale 
(‘perfectly’ 
to ‘not at 
all’) 
Underwent a substantial revision 
resulting in omissions, modifications 
and addition of items such that the 
burdens and restrictions sub-scales 
comprise an additional 13 items, yet 
the validation work underpinning this 
has not been published. An English 
language version was subsequently 
developed (Cooke et al., 2013). 
English language version 
demonstrated internal reliability 
(α=.85-.94), concurrent validity (D-
SQoL), discriminant validity 
(depressed mood, generic QoL, and 
life satisfaction) and known-groups 
validity (presence of diabetes-related 
complications) at the full-scale and 
sub-scale level in T1D using baseline 
data across three UK DAFNE study 
sites (Cooke et al., 2013).  
IPQ-R:  
Illness 
Perceptions 
Questionnaire – 
Revised  
 
880 citations 
(2014) 
‘Emotional 
Representations
’ (6) 
‘Indicate how much you 
agree or disagree with 
the following statements 
about your diabetes’ 
(and prompted ‘we are 
interested in your own 
personal views of how 
you see your diabetes’) 
‘I get depressed when 
I think about my 
illness’
a 
and ‘My 
illness makes me feel 
afraid’
a 
5 point 
scale 
(‘strongly 
disagree’ 
to 
‘strongly 
agree’) 
Quantitative assessment of the 5 
dimensions of cognitive 
representations of illness 
(Leventhal’s Self-Regulatory Model); 
identity, consequences, timeline, 
control/cure and cause (items 
derived theoretically to assess these 
dimensions, by the authors and via 
patient interviews). Subsequently 
revised to improve measurement 
properties and extend scope; new 
items added, existing structure 
altered, and two subscales added; 
‘illness coherence’ and ‘emotional 
representations’ (a previously 
overlooked component of 
Leventhal’s model; items tap 6 
affective responses to illness proven 
to be sensitive to differences in 
illness perceptions and predict health 
behaviors) (Moss-Morris et al., 2002). 
IPQ-R was then validated in 8 UK 
patient groups including diabetes. 
Internal reliability (α=.79-.89) and 
predictive, known-groups and 
discriminant validity were established 
for full measure and sub-scales; only 
the latter was established in diabetes 
(i.e. a discriminant association with 
general affective disposition) (Moss-
Morris et al., 2002). 
 
N/A: Not applicable; DD: diabetes distress; T1D: Type 1 diabetes; T2D: Type 2 diabetes; BMI: body mass index; QoL: quality of life; D-SQoL: diabetes-specific QoL; HCPs: 
health care professionals.  
a
Emotional distress elicited via the item wording irrespective of the completion instructions or response options.  
b
Emotional distress elicited via the completion instructions or response options only.  
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c
Cognitive appraisal of the personal impact of diabetes elicited: emotional distress not elicited via the item wording, completion instructions or response options.  
†At the time that the citation search was undertaken only a conference paper, published within the previous three years, was available reporting on the development of 
the T1-DDS hence this was included as a potentially emerging measure. 
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Table 3 Content validity of the measures of diabetes distress 
 
Content validity of the measures of diabetes distress highlighting variation in the operationalization of the construct. 
 
 
Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Treatment 
regimen 
Feeling guilty / a 
failure in relation 
to managing 
diabetes 
Feelings of guilt or 
anxiety when you get off 
track with your diabetes 
management (#13) 
Feeling that I am often 
failing with my diabetes 
routine (#6) 
Feeling that I am not 
as skilled at managing 
diabetes as I should be 
(#1) 
I worry about the 
management of my 
diabetes (#19) 
  
Feeling that I am not 
testing my blood sugars 
frequently enough (#5) 
Feeling that I have got 
to be perfect with my 
diabetes management 
(#21) 
Not feeling confident in 
my day-to-day ability to 
manage diabetes (#10) 
Feeling that I am not 
taking as much insulin 
as I should (#8) 
Feeling that I don’t 
check my blood 
glucose levels as often 
as I probably should 
(#12) 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Feeling that I don’t 
give my diabetes as 
much attention as I 
probably should (#28) 
Feeling 
despondent / 
unmotivated  
regarding 
diabetes 
management 
Feeling discouraged with 
your diabetes treatment 
plan (#2) 
Not feeling motivated to 
keep up my diabetes 
self-management (#16) 
Feeling discouraged 
when I see high blood 
glucose numbers that I 
can’t explain (#5) 
I feel a sense of 
satisfaction from 
managing my 
diabetes (#26) 
  
Feeling that no matter 
how hard I try with my 
diabetes, it will never 
be good enough (#25) 
Feeling burdened 
by diabetes 
management  
 
 
  Feeling that there is 
too much diabetes 
equipment and stuff I 
must always take with 
me (#9) 
I feel stressed by 
keeping to a 
schedule with my 
diabetes (#23) 
It bothers me that 
I have to spend so 
much time on my 
diabetes 
treatment (#1) 
It bothers me that 
I have to measure 
my blood glucose 
so often (#1) 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
 I feel positive about 
my diabetes 
management (#27) 
It bothers me that 
I have to take my 
diabetes supplies 
(e.g. blood testing 
equipment) with 
me whatever I do 
(#45) 
Food / eating 
Feeling deprived 
regarding food 
and  eating 
Feelings of deprivation 
regarding food and 
meals (#5) 
     
Feeling pre-
occupied and 
controlled by 
dietary 
requirements 
Feeling constantly 
concerned about food 
and eating (#11) 
 Feeling that thoughts 
about food and eating 
control my life (#16) 
 It is a burden for 
me that I need to 
constantly think 
about my food 
plan (#2) 
 
Feeling unable to 
comply with 
dietary 
requirements  
 
 
Feeling that I am not 
sticking closely enough 
to a good meal plan 
(#12) 
Feeling that I don’t eat 
as carefully as I 
probably should (#2) 
   
Feeling that my eating 
is out of control (#23) 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Negative 
emotional 
experiences  
related to 
diabetes  
Feeling 
overwhelmed by 
diabetes 
Feeling that diabetes is 
taking up too much of 
your mental and 
physical energy every 
day (#16) 
Feeling that diabetes is 
taking up too much of 
my mental and physical 
energy every day (#1) 
    
Experiencing 
negative affect 
relating  to 
diabetes 
Feeling depressed when 
you think about living 
with diabetes (#6) 
Feeling angry, scared, 
and/or depressed when 
I think about living with 
diabetes (#3) 
 
 
 
 
 
Talking or thinking 
about my diabetes 
gets me upset or 
feeling downhearted 
(#17) 
 
 
 
 
 
I get depressed 
when I think about 
my diabetes (#1)  
Feeling scared when you 
think about living with 
diabetes (#3) 
Because of my 
diabetes I get 
depressed (#18) 
Having diabetes 
makes me feel 
anxious (#5) 
Feeling angry when you 
think about living with 
diabetes (#10) 
I feel irritated by my 
diabetes (#24) 
When I think 
about my illness I 
get upset (#2) 
I feel frustrated that 
I have to live with 
diabetes (#22) 
My diabetes 
makes me feel 
afraid (#6) 
My diabetes 
makes me feel 
angry (#3) 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Feeling 
overwhelmed / 
burned out 
because of 
diabetes 
Feeling that diabetes is 
taking up too much of 
your mental and 
physical energy every 
day (#16) 
Feeling that diabetes is 
taking up too much of 
my mental and physical 
energy every day (#1) 
 Managing my 
diabetes means I 
have too many 
things to do (#21) 
  
Feeling overwhelmed by 
your diabetes (#8) 
Feeling overwhelmed by 
the demands of living 
with diabetes (#14) 
I feel I can cope with 
the challenges my 
diabetes might 
present (#28) Feeling ‘burned out’ by 
the constant effort 
needed to manage 
diabetes (#20) 
Acceptance of 
diabetes 
Not ‘accepting’ your 
diabetes (#14) 
  I feel well adjusted 
to my diabetes (#25) 
 My diabetes does 
not worry me (#4) 
Feeling confused 
about the  
emotional impact 
of diabetes  
Not knowing if your 
mood or feelings are 
related to your diabetes 
(#7) 
     
Feeling  
controlled by 
diabetes 
 Feeling that diabetes 
controls my life (#8) 
  It bothers me how 
much diabetes 
controls my life 
(#53) 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Future / 
complications 
Fear of 
complications/ 
the future 
Worrying about the 
future and the 
possibility of 
complications (#12) 
Feeling that I will end up 
with serious long-term 
complications, no 
matter what I do (#11) 
Feeling worried that I 
will develop serious 
long-term 
complications no 
matter how hard I try 
(#13) 
Because of my 
diabetes I worry 
about the future 
(#20) 
  
Coping with 
existing 
complications 
Coping with 
complications of 
diabetes (#19) 
     
Hypoglycemia Worry about  
hypoglycemia   
Worrying about low 
blood sugar reactions 
(#9) 
 Feeling frightened that 
I could have a serious 
hypoglycemic event 
when I’m asleep (#15) 
   
Feeling frightened that 
I could have a serious 
hypoglycemic event 
while driving (#22) 
Feeling that I can’t 
ever be safe from the 
possibility of a 
hypoglycemic event 
(#27) 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Worry about 
hypoglycemic 
unawareness 
  Feeling that I don’t 
notice the warning 
signs of hypoglycemia 
as well as I used to 
(#3) 
   
Social /  
interpersonal  
 
 
 
 
 
Unhelpful behaviour  
from friends and 
family relating to 
diabetes  
 
Uncomfortable social 
situations related to 
your diabetes care (e.g. 
people telling you what 
to eat) (#4) 
 Feeling that my family 
and friends make a 
bigger deal out of 
diabetes than they 
should (#6) 
   
Feeling that my friends 
of family act like 
“diabetes police” 
(bother me too much) 
(#20) 
   
Feeling that friends 
and family do not 
understand  
 Feeling that friends of 
family don’t appreciate 
how difficult living with 
diabetes can be (#13) 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Feeling unsupported 
by friends and family 
in relation to 
diabetes 
Feeling that your friends 
and family are not 
supportive of your 
diabetes management 
efforts (#18) 
Feeling that friends or 
family are not 
supportive enough of 
self-care efforts (e.g. 
planning activities that 
conflict with my 
schedule, encouraging 
me to eat the ‘wrong’ 
foods) (#7) 
    
Feeling alone with 
diabetes 
Feeling alone with your 
diabetes (#17) 
Feeling that friends or 
family don’t give me the 
emotional support that I 
would like (#17)*** 
Feeling that I have to 
hide my diabetes from 
other people (#10) 
   
Feeling that people 
treat you differently 
because of diabetes  
  Feeling that my friends 
and family worry more 
about hypoglycemia 
than I want them to 
(#11) 
   
Feeling that my friends 
or family treat me as if 
I were more fragile or 
sicker than I really am 
(#17)*** 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Feeling that people 
treat me differently 
when they find out I 
have diabetes (#4) 
Feeling that people 
will think less of me 
when if they knew I 
had diabetes (#24) 
Fear of 
discrimination in 
relation to 
employment 
  Feeling concerned that 
diabetes may make 
me less attractive to 
employers (#19) 
   
Health care 
professionals 
Feeling that HCPs do 
not  have enough 
knowledge about 
diabetes 
 Feeling that my doctor 
doesn’t know enough 
about diabetes and 
diabetes care (#2) 
Feeling that my doctor 
doesn’t know enough 
about diabetes and 
diabetes care (#26) 
   
Feeling that my 
diabetes doctor 
doesn’t really 
understand what it’s 
like to have diabetes 
(#18) 
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Aspect of DD 
PAID: Problem Areas in 
Diabetes 
(20 items) 
DDS: Diabetes Distress 
Scale 
(17 items) 
T1-DDS: Type 1 
Diabetes Distress Scale 
(28 items) 
W-BQ28: Well-being 
Questionnaire 28 
(‘Diabetes Well-
being’ sub-scale) 
(12 items) 
DSQoLs-R: 
Diabetes-specific 
Quality of life 
Scale-Revised  
(’Daily Hassles’ 
sub-scale) 
(5 items) 
IPQ-R: Illness 
Perceptions 
Questionnaire – 
Revised  
(‘Emotional 
Representations’ 
sub-scale) 
(6 items) 
Negative emotion 
about diabetes self-
management goals 
from HCPs 
Not having clear and 
concrete goals for your 
diabetes care (#1) 
Feeling that my doctor 
doesn’t give me clear 
enough directions on 
how to manage my 
diabetes (#4) 
 
 
   
Feeling unsupported 
by HCPs  
 
 
Feeling unsatisfied with 
your diabetes physician 
(#15) 
Feeling that I don’t get 
help I really need from 
my diabetes doctor 
about managing 
diabetes (#14)  
   
Feeling that I don’t have 
a doctor who I can see 
regularly enough about 
my diabetes (#15) 
Feeing that I can’t tell 
my diabetes doctor 
what is really on my 
mind (#7) 
Feeling that my doctor 
doesn’t take my 
concerns seriously 
enough (#9)*** 
 
DD: diabetes distress; HCPs: Health care professionals.  
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Figure 1 Flow diagram  
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Highlights 
 This paper presents a conceptualization and operationalization of diabetes distress based on 
the extant evidence base; DD is characterized by a range of negative emotional responses 
(e.g. worry, fear, frustration, guilt, sadness, anger, overwhelm), to aspects of living with and 
managing diabetes balanced against an appraisal of available coping resources. 
 
 This paper distinguishes six measures of diabetes distress from the vast array of diabetes-
specific patient-reported outcome measures in existence, only three of which have 
previously been considered for this purpose. 
 
 This paper brings to the fore that existing measures of DD differ in their focus and scope; 
none appears to be fully comprehensive and hence selection decisions should be informed 
by consideration of their unique focus and scope to ensure that the foci of interventions are 
appropriately targeted. 
